Euclidean Technologies Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-25,239
Closed -$2.4M 70
2018
Q3
$2.4M Sell
25,239
-5,700
-18% -$486K 2.12% 11
2018
Q2
$2.39M Buy
30,939
+1,700
+6% +$128K 2.23% 6
2018
Q1
$2.02M Hold
29,239
1.99% 17
2017
Q4
$2.18M Sell
29,239
-2,600
-8% -$166K 2.15% 10
2017
Q3
$2.02M Buy
+31,839
New +$1.98M 1.93% 26

Other funds holding ESRX

Euclidean Technologies Management's ESRX Position: Q4 2018 in Review

Euclidean Technologies Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 25,239 shares — an estimated $2.4M sold.

Euclidean Technologies Management first reported a position in ESRX in Q3 2017 and held it in 5 quarters. The position peaked at $2.4M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Euclidean Technologies Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Euclidean Technologies Management sold 25,239 Express Scripts Holding Company shares in Q4 2018, an estimated $2.4M.
  • Euclidean Technologies Management first reported a position in Express Scripts Holding Company in Q3 2017 and held it in 5 quarters.
  • Euclidean Technologies Management's Express Scripts Holding Company position peaked at $2.4M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Euclidean Technologies Management's 13F filing for Q4 2018, filed 14 Feb 2019.